Similar articles

• The effect of thymosin on glucocorticoid receptors in lymphoid cells.

  Osheroff PL. Osheroff PL. Cell Immunol. 1981 May 15;60(2):376-85. doi: 10.1016/0008-8749(81)90279-3. Cell Immunol. 1981. PMID: 6972268 No abstract available.
• Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.

  Abiko T, Sekino H. Abiko T, et al. Chem Pharm Bull (Tokyo). 1991 Oct;39(10):2647-52. doi: 10.1248/cpb.39.2647. Chem Pharm Bull (Tokyo). 1991. PMID: 1806285
• Recovery of T-cell functions in aged mice injected with synthetic thymosin-alpha 1.

  Frasca D, Garavini M, Doria G. Frasca D, et al. Cell Immunol. 1982 Sep 15;72(2):384-91. doi: 10.1016/0008-8749(82)90487-7. Cell Immunol. 1982. PMID: 6758954 No abstract available.
• Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.

  Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
• Clinical applications of thymosin alpha-1.

  Goldstein AL. Goldstein AL. Cancer Invest. 1994;12(5):545-7. doi: 10.3109/07357909409021415. Cancer Invest. 1994. PMID: 7922712 Review. No abstract available.